Capsida Biotherapeutics

White arrow on a road pointing to the rising sun

Biotech

AbbVie exercises $40M option for Capsida-partnered gene therapy

AbbVie decided to opt-in based on data showing that Capsida’s viral capsids were able to deliver AbbVie’s gene therapy to the brains of primates.

Darren Incorvaia Jan 7, 2025 10:45am

parachutes peru

Another Biogen exec hitches ride to Voyager —Chutes & Ladders

Mar 15, 2024 9:30am

Los Angeles

VC launches biotech fund with $450M and 'recipe for success'

Jul 17, 2023 12:26pm

layoffs job losses cuts workforce reduction

Capsida cuts staff even with AbbVie, Lilly deals on the books

Jul 14, 2023 12:32pm

eyeball retinal diseases

AbbVie pays $70M to expand Capsida collab into eye disease

Feb 23, 2023 5:00am

Eli Lilly

Lilly pays $55M to join AbbVie on AAV specialist's partner list

Jan 4, 2023 7:45am